We found that activation of TLR8 signaling in tumor cells can block tumor-induced conversion of naïve and tumor-specific T cells into senescent cells and reverse senescent T-cell-mediated suppression, resulting in enhanced anti-tumor immunity in vivo. Here, TLR8 is linked to neoplasm.